Skip to main
University-wide Navigation

Antibiotics Could Be Promising Treatment for Form of Dementia

Researchers at UK's College of Medicine have found that a class of antibiotics could be promising treatment for a form of dementia. Results of their proof of concept study were recently published in the journal Human Molecular Genetics.

When is Alzheimer's Not Alzheimer's? Researchers Characterize a Different Form of Dementia

In the past, using "Alzheimer’s disease" & "dementia" interchangeably was a generally accepted practice. Now there's rising appreciation that a variety of diseases & disease processes contribute to dementia.

A Low Dose Aspirin for Dementia? Drug Ready for Human Testing

Linda Van Eldik, director of the UK Sanders-Brown Center on Aging, received $5.5 million from NIH and the Alzheimer's Drug Discovery Foundation. She developed a drug that is ready for its first round of testing in humans.

Does Smoking Cause Dementia? Maybe Not, Study Says

It's an irrefutable fact that smoking is bad for you. Study after study has proven that smoking increases your risk for cancer, heart disease, diabetes – even blindness. But dementia? Not so fast. A recent study has demonstrated that smoking is not associated with a higher risk of dementia.

Research Identifies Potential Predictors of Vascular Cognitive Impairment and Dementia in Alzheimer's

Research from the Sanders-Brown Center on Aging presented at the Society for Neuroscience annual meeting has identified two potential ways to predict vascular cognitive impairment and dementia (VCID) – the second leading cause of dementia behind Alzheimer's disease.

Register for Markesbery Symposium's Scientific, Community Sessions

The 8th Annual Sanders-Brown Center on Aging's Markesbery Symposium will take place Oct. 26-27.

Sanders-Brown Grant Trains New Generation of Dementia Researchers

The University of Kentucky Sanders-Brown Center on Aging has been awarded a $2 million grant to train the next generation of dementia researchers.

Filter News